John P. Sharp
2010 - Ligand Pharmaceuticals
In 2010, John P. Sharp earned a total compensation of $479.2K as Vice President, Finance and Chief Financial Officer at Ligand Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $74,578 |
|---|---|
| Option Awards | $109,360 |
| Salary | $262,600 |
| Stock Awards | $29,880 |
| Other | $2,810 |
| Total | $479,228 |
Sharp received $262.6K in salary, accounting for 55% of the total pay in 2010.
Sharp also received $74.6K in non-equity incentive plan, $109.4K in option awards, $29.9K in stock awards and $2.8K in other compensation.
Rankings
In 2010, John P. Sharp's compensation ranked 7,856th out of 10,439 executives tracked by ExecPay. In other words, Sharp earned more than 24.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,856 out of 10,439 | 25th |
Division Manufacturing | 2,920 out of 3,838 | 24th |
Major group Chemicals And Allied Products | 694 out of 921 | 25th |
Industry group Drugs | 481 out of 680 | 29th |
Industry Pharmaceutical Preparations | 361 out of 481 | 25th |
Source: SEC filing on April 25, 2013.
Sharp's colleagues
We found two more compensation records of executives who worked with John P. Sharp at Ligand Pharmaceuticals in 2010.